Corneal confocal microscopy detects corneal nerve damage and increased dendritic cells in Fabry disease

[1]  Stanley S. Ipson,et al.  A fully automated cell segmentation and morphometric parameter system for quantifying corneal endothelial cell morphology , 2018, Comput. Methods Programs Biomed..

[2]  R. Malik,et al.  Corneal Confocal Microscopy Detects Corneal Nerve Damage in Patients Admitted With Acute Ischemic Stroke , 2017, Stroke.

[3]  A. Karahalios,et al.  Laser scanning in vivo confocal microscopy (IVCM) for evaluating human corneal sub-basal nerve plexus parameters: protocol for a systematic review , 2017, BMJ Open.

[4]  S. Feriozzi,et al.  Contribution of inflammatory pathways to Fabry disease pathogenesis. , 2017, Molecular genetics and metabolism.

[5]  F. Stapleton,et al.  A pilot study on corneal Langerhans cells in keratoconus. , 2017, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[6]  H. Hartung,et al.  PERIPHERAL NEUROPATHIES: CIDP and other inflammatory neuropathies in diabetes — diagnosis and management , 2017 .

[7]  R. Malik,et al.  Corneal confocal microscopy is a rapid reproducible ophthalmic technique for quantifying corneal nerve abnormalities , 2017, PloS one.

[8]  Adnan Khan,et al.  Corneal Confocal Microscopy: An Imaging Endpoint for Axonal Degeneration in Multiple Sclerosis. , 2017, Investigative ophthalmology & visual science.

[9]  Richard B. Thompson,et al.  Clinical Features, Diagnosis, and Management of Patients With Anderson-Fabry Cardiomyopathy. , 2017, The Canadian journal of cardiology.

[10]  T. Peto,et al.  Use of Corneal Confocal Microscopy to Evaluate Small Nerve Fibers in Patients With Human Immunodeficiency Virus , 2017, JAMA ophthalmology.

[11]  Rayaz A. Malik,et al.  Use of Corneal Confocal Microscopy to Detect Corneal Nerve Loss and Increased Dendritic Cells in Patients With Multiple Sclerosis , 2017, JAMA ophthalmology.

[12]  A. Dahan,et al.  Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain. , 2017, Investigative ophthalmology & visual science.

[13]  S. G. Yılmaz,et al.  A novel mutation and in vivo confocal microscopic findings in Fabry disease , 2017, Saudi Journal of Ophthalmology.

[14]  A. Ortiz,et al.  The Prevalence of Fabry Disease in Patients with Chronic Kidney Disease in Turkey: The TURKFAB Study , 2016, Kidney and Blood Pressure Research.

[15]  H. Hartung,et al.  Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy , 2015, Annals of clinical and translational neurology.

[16]  K. Chaudhuri,et al.  Small fiber neuropathy in Parkinson's disease: A clinical, pathological and corneal confocal microscopy study , 2015, Parkinsonism & related disorders.

[17]  R. Malik,et al.  Corneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral Neuropathy , 2015, PloS one.

[18]  T. Segura,et al.  Cerebral hemodynamics and endothelial function in patients with Fabry disease , 2013, BMC Neurology.

[19]  C. Wanner,et al.  Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case–control study , 2013, BMC Neurology.

[20]  A. Kampik,et al.  Distribution of Antigen Presenting Cells in the Human Cornea: Correlation of In Vivo Confocal Microscopy and Immunohistochemistry in Different Pathologic Entities , 2012, Current eye research.

[21]  Mitra Tavakoli,et al.  Corneal confocal microscopy detects small‐fiber neuropathy in Charcot–Marie–Tooth disease type 1A patients , 2012, Muscle & nerve.

[22]  C. Vargas,et al.  Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy. , 2012, Biochimica et biophysica acta.

[23]  C. Sommer,et al.  Small fibers in Fabry disease: baseline and follow‐up data under enzyme replacement therapy , 2011, Journal of the peripheral nervous system : JPNS.

[24]  M. A. Dabbah,et al.  Automatic analysis of diabetic peripheral neuropathy using multi-scale quantitative morphology of nerve fibres in corneal confocal microscopy imaging , 2011, Medical Image Anal..

[25]  Pedram Hamrah,et al.  Inflammation and the nervous system: the connection in the cornea in patients with infectious keratitis. , 2011, Investigative ophthalmology & visual science.

[26]  N. Pfeiffer,et al.  Confocal laser-scanning microscopy allows differentiation between Fabry disease and amiodarone-induced keratopathy , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.

[27]  A. Boulton,et al.  Increased Langerhan cell density and corneal nerve damage in diabetic patients: role of immune mechanisms in human diabetic neuropathy. , 2011, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[28]  R. Mignani,et al.  Small fiber neuropathy in female patients with fabry disease , 2010, Muscle & nerve.

[29]  Nathan Efron,et al.  Corneal confocal microscopy: A novel noninvasive means to diagnose neuropathy in patients with fabry disease , 2009, Muscle & nerve.

[30]  Nathan Efron,et al.  Corneal confocal microscopy: A novel means to detect nerve fibre damage in idiopathic small fibre neuropathy , 2009, Experimental Neurology.

[31]  C. A. Fossati,et al.  Leukocyte perturbation associated with Fabry disease , 2009, Journal of Inherited Metabolic Disease.

[32]  P. Denis,et al.  Relation entre les manifestations ophtalmologiques et les atteintes générales chez dix patients atteints de la maladie de Fabry , 2008 .

[33]  P. Rozenfeld,et al.  High incidence of autoantibodies in Fabry disease patients , 2007, Journal of Inherited Metabolic Disease.

[34]  J. Clarke.  Narrative Review: Fabry Disease , 2007, Annals of Internal Medicine.

[35]  A. Mehta,et al.  Ocular manifestations of Fabry’s disease: data from the Fabry Outcome Survey , 2006, British Journal of Ophthalmology.

[36]  J. Kriegsmann,et al.  IgA nephropathy in two adolescent sisters heterozygous for Fabry disease , 2006, Pediatric Nephrology.

[37]  R. Schiffmann,et al.  Enzyme replacement therapy and intraepidermal innervation density in Fabry disease , 2006, Muscle & nerve.

[38]  M. Beck.  The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease. , 2006, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[39]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[40]  A. Mehta,et al.  Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey , 2004, European journal of clinical investigation.

[41]  D. F. Moore,et al.  Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease , 2003, Muscle & nerve.

[42]  U. Ramaswami,et al.  The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents , 2003, European Journal of Pediatrics.

[43]  R. A. Malik,et al.  Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients , 2003, Diabetologia.

[44]  J. Dambrosia,et al.  Physiological characterization of neuropathy in Fabry's disease , 2002, Muscle & nerve.

[45]  K. Macdermot,et al.  Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males , 2001, Journal of medical genetics.

[46]  D. F. Moore,et al.  Enzyme replacement therapy in Fabry disease: a randomized controlled trial. , 2001, JAMA.

[47]  R. A. Wevers,et al.  The frequency of lysosomal storage diseases in The Netherlands , 1999, Human Genetics.

[48]  T. Crawford,et al.  Quantitative analysis of epidermal innervation in Fabry disease , 1999, Neurology.

[49]  D. Gladman,et al.  Coexistence of Fabry's disease and systemic lupus erythematosus. , 1998, Clinical and experimental rheumatology.

[50]  K. Toyooka,et al.  Nerve biopsy findings in hemizygous and heterozygous patients with Fabry’s disease , 1997, Journal of Neurology.

[51]  P. Dyck,et al.  Loss of small peripheral sensory neurons in Fabry disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns. , 1974, Archives of neurology.

[52]  P. Kahn.  Anderson-Fabry disease: a histopathological study of three cases with observations on the mechanism of production of pain , 1973, Journal of neurology, neurosurgery, and psychiatry.

[53]  Huichao Feng,et al.  A protocol for a systematic review , 2019 .

[54]  K. Satoh.  Globotriaosylceramide induces endothelial dysfunction in fabry disease. , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[55]  P. Luna,et al.  [Fabry disease]. , 2009, Anais brasileiros de dermatologia.

[56]  P. Cochat,et al.  [Relation between ocular manifestations and organ involvement in ten patients with Fabry disease]. , 2005, Journal Francais d'Ophtalmologie.

[57]  E. Govoni,et al.  Pathological study of the sural nerve in Fabry's disease. , 1984, European neurology.